Methods for identifying safe and functional humanized antibodies
US9221900B2 · kind B2 · utility
3Cited by
112References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 29, 2011 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Mar 29, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is related to safe and functional antibodies for the therapeutic and diagnostic use in the treatment of an amyloidosis, a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.